炎症细胞向输送系统用于心肌梗塞治疗
Wenyuan Zhang1, Dan Peng1, Shiqi Cheng1
1Department of Pharmacy, Daping Hospital, Army Medical University, Chongqing 400042, China.
Bioengineering (Basel, Switzerland)
|February 26, 2025
概括
有针对性的药物输送系统可以通过调节炎症来有效治疗心肌梗塞 (MI). 使用免疫细胞特异性传递的新型疗法在治疗心脏功能障碍和心脏病发作后重塑方面表现有前途.
科学领域:
- 心血管科学 心血管科学
- 免疫学 免疫学 免疫学
- 生物医学工程 生物医学工程
背景情况:
- 心肌梗塞 (MI) 是全球主要的死亡原因,其特征是炎症反应,可能导致不良的心脏重塑.
- 在心脏病发作后不受控制的炎症导致心脏功能障碍,痕和患者的不良结果.
- 有效的炎症调节治疗对于管理心脏病发作和改善患者预后至关重要.
研究的目的:
- 审查免疫细胞和纤维细胞参与MI的病变发生.
- 总结针对心脏病发作治疗的新型药物输送系统,重点关注炎症细胞向.
- 突出最近发展的趋势和策略,开发针对性治疗MI.
主要方法:
- 在心肌梗塞中免疫反应的文献综述.
- 新兴药物输送系统的概述,包括水凝,心脏贴片,纳米颗粒和细胞外囊泡.
- 分析炎症细胞向治疗心脏病的策略.
主要成果:
- 确定了导致心脏病发作进展的关键免疫细胞和纤维细胞.
- 详细介绍了各种先进的药物输送平台,旨在针对性治疗.
- 强调了专门针对炎症细胞的策略的潜力,以加强心脏病发作治疗.
结论:
- 向药物输送系统通过调节炎症反应,为心肌梗塞提供了一个有希望的治疗途径.
- 像纳米颗粒和电动汽车这样的新型输送系统显示出精确向炎症部位输送的潜力.
- 进一步开发这些有针对性的策略对于有效的MI管理和改善心血管健康至关重要.
相关概念视频
Modified-Release Drug Delivery Systems: Site-Targeted
Site-targeted drug delivery systems enhance therapeutic efficacy while minimizing systemic toxicity and treatment costs. Unlike conventional methods, these systems ensure precise drug delivery, improving bioavailability and reducing side effects. Targeted drug delivery is classified into three levels. First-order targeting directs drugs to the capillary beds of specific organs or tissues. Second-order targets specific cell types, such as tumor cells, using receptor-mediated interactions.
Myocarditis I: Introduction
Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Myocarditis III: Medical Management
Myocarditis: Comprehensive Medical ManagementMyocarditis, the heart muscle inflammation, requires a comprehensive medical management strategy that addresses the underlying cause, provides supportive care, manages symptoms, and reduces cardiac workload.Infections and Autoimmune CausesAdminister appropriate antimicrobial therapy when an infectious agent causes myocarditis. For instance, penicillin treats infections caused by Group A Streptococcus. In cases where autoimmune processes are...
Acute Coronary Syndrome IV: Interprofessional Care
IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...


